These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4981466)

  • 21. Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus.
    Gitlin D; Biasucci A
    J Clin Invest; 1969 Aug; 48(8):1433-46. PubMed ID: 5796355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of plasminogen - free fibrinogen; starting from fibrinogen prepared by improved freezing thawing method.
    Sato T; Aoki N; Asada T
    Jpn J Exp Med; 1969 Apr; 39(2):135-42. PubMed ID: 5308445
    [No Abstract]   [Full Text] [Related]  

  • 23. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood fibrinolytic system in rana tigrina.
    Srivastava VM; Dube B; Dube RK; Agarwal GP; Ahmad N
    Thromb Haemost; 1981 Jun; 45(3):252-4. PubMed ID: 7281104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Difference between serum and euglobulin in the determination of fibrinolytic activity by streptokinase: differences of fibrinolytic activity in various diseases].
    Miyatani K; Fukui I
    Rinsho Byori; 1970 Jul; 18(7):512-4. PubMed ID: 5466544
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gel filtration of immune lactoserum of sephadex G-50].
    Kholin IuA; Uziumov VL; Chunaev IuV
    Veterinariia; 1979 Jan; (1):77-8. PubMed ID: 419680
    [No Abstract]   [Full Text] [Related]  

  • 28. The fibrinolytic activity of red blood cells.
    Tymiński W; Czestochowska E
    Pol Med J; 1966; 5(2):231-8. PubMed ID: 5915707
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphine.
    Buczko W; Wiśniewski K
    Thromb Diath Haemorrh; 1972 Dec; 28(3):359-66. PubMed ID: 4265317
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma.
    Lämmle B; Noll G; Tran TH; Lohri A; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):403-5. PubMed ID: 6548585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolysis of pleural exudates].
    Blatný J; Oral I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):39-42. PubMed ID: 4244001
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
    Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
    Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibrinolysis: studies on the significance of euglobulin clot lysis time and re-examination of its estimation method].
    Ishii S; Kimura T; Numakami A; Ito S; Azumagawa T; Kikuchi N
    Kanagawa Shigaku; 1985 Sep; 20(2):271-81. PubMed ID: 3869263
    [No Abstract]   [Full Text] [Related]  

  • 39. The mechanism of activation of cat plasma by streptokinase.
    Mootse G; Fleming LB; Cliffton EE
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):562-79. PubMed ID: 5865611
    [No Abstract]   [Full Text] [Related]  

  • 40. [An automatic method for determination of euglobulin lysis time].
    Craveri A; Mannucci PM; Mari D; Bossi GP
    Minerva Med; 1973 Dec; 64(86):4558-64. PubMed ID: 4272416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.